New hope for FSGS: experimental drug enters Mid-Stage trial

NCT ID NCT07268638

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental drug called praliciguat in 60 adults with a rare kidney disease called FSGS. The goal is to see if it can reduce protein in the urine, a sign of kidney damage. Participants will first receive either the drug or a placebo for 24 weeks, then everyone can take the drug for another 24 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FOCAL SEGMENTAL GLOMERULOSCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic renal failure syndrome focal segmental glomerulosclerosis proteinuria

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Investigator Site # 1

    RECRUITING

    Lawrenceville, Georgia, 30046, United States

  • Investigator Site #10

    RECRUITING

    Pontiac, Michigan, 48341, United States

  • Investigator Site #11

    RECRUITING

    Louisville, Kentucky, 40205, United States

  • Investigator Site #12

    RECRUITING

    San Dimas, California, 91773, United States

  • Investigator Site #13

    RECRUITING

    Arvada, Colorado, 80002, United States

  • Investigator Site #14

    RECRUITING

    Los Angeles, California, 90022, United States

  • Investigator Site #2

    RECRUITING

    Chula Vista, California, 91910, United States

  • Investigator Site #3

    TERMINATED

    Chicago, Illinois, 60643, United States

  • Investigator Site #4

    RECRUITING

    Chattanooga, Tennessee, 37404, United States

  • Investigator Site #5

    RECRUITING

    Arlington, Texas, 76015, United States

  • Investigator Site #6

    RECRUITING

    Coral Springs, Florida, 33071, United States

  • Investigator Site #7

    RECRUITING

    Miami, Florida, 33172, United States

  • Investigator Site #8

    RECRUITING

    Orlando, Florida, 32806, United States

  • Investigator Site #9

    RECRUITING

    Dallas, Texas, 75231, United States